Table 2 Baseline demographic and clinical characteristics of the study population.
Characteristics | Normal (n = 72) | Ischemia (n = 51) | Infarct (n = 58) | p-value |
|---|---|---|---|---|
Male gender | 25 (34.7%) | 30 (58.8%) | 40 (69.0%) | < 0.001 |
Age (years) | 70.89 ± 10.45 | 71.20 ± 11.65 | 66.84 ± 12.36 | 0.074 |
BMI (kg/m2) | 25.29 ± 3.66 | 25.47 ± 3.97 | 25.63 ± 6.99 | 0.929 |
HR (beats/min) | 71.97 ± 14.27 | 73.98 ± 12.36 | 72.72 ± 13.15 | 0.715 |
SBP (mmHg) | 136.51 ± 21.17 | 136.65 ± 17.15 | 125.69 ± 20.02 | 0.003 |
DBP (mmHg) | 75.32 ± 12.86 | 75.10 ± 11.30 | 74.16 ± 14.44 | 0.871 |
Risk factor | ||||
Smoking | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
Hypercholesterolemia | 35 (48.6%) | 31 (60.8%) | 30 (51.7%) | 0.399 |
Diabetes mellitus | 27 (37.5%) | 28 (54.9%) | 28 (48.3%) | 0.146 |
Hypertension | 60 (83.3%) | 40 (78.4%) | 43 (74.1%) | 0.438 |
Family history of IHD | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
Medications | ||||
Beta-blocker | 34 (47.2%) | 36 (70.6%) | 47 (81.0%) | < 0.001 |
CCB | 26 (36.1%) | 19 (37.3%) | 7 (12.1%) | 0.003 |
Nitrates | 5 (6.9%) | 16 (31.4%) | 8 (13.8%) | 0.001 |
Aspirin | 28 (38.9%) | 45 (88.2%) | 52 (89.7%) | < 0.001 |
ACEI | 7 (9.7%) | 4 (7.8%) | 17 (29.3%) | 0.002 |
ARB | 21 (29.2%) | 12 (23.5%) | 38 (34.5%) | 0.455 |
Statin | 40 (55.6%) | 41 (80.4%) | 48 (82.8%) | 0.001 |
CMR data | ||||
LVEF (%) | 74.19 ± 9.43 | 64.49 ± 14.32 | 48.95 ± 15.78 | < 0.001 |
Left ventricular mass (g) | 78.37 ± 22.38 | 88.81 ± 22.15 | 101.43 ± 36.93 | < 0.001 |
Cardiac output (L/min) | 5.9 ± 1.73 | 5.9 ± 1.33 | 5.69 ± 2.43 | 0.796 |
Stroke volume (ml) | 82.18 ± 18.04 | 80.42 ± 15.76 | 78.89 ± 29.02 | 0.689 |
